International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia

NCT01117441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6136

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: PEG-L-asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: prednisone
DRUG: thioguanine
DRUG: vincristine sulfate
DRUG: vindesine
DRUG: daunoxome
DRUG: fludarabine
RADIATION: Radiation Therapy

Sponsor

University Hospital Schleswig-Holstein

Collaborators

[object Object]